Enzene Inc.
Featured Exhibitors
Information
Enzene an integrated global CDMO, offers services spanning discovery, development and commercial supply. Its patented fully-connected continuous manufacturing(TM) (FCCM(TM)) platform, EnzeneX(TM), is validated for commercial biologics supply and demonstrates significantly increased production yields and reduced costs. Enzene aims to lower mAb production costs below $40/gram by 2025. Our microbial and mammalian drug substance plants, as well as our sterile fill & finish plant in India are EU-GMP certified.Visit www.enzene.com.
Zone
Contract Manufacturing and Services
Organization Type
CMO/CDMO
Country
United States
Business Activity
Animal HealthBiopharmaceuticalContract Manufacturer
Markets Active In
North America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)
Product Types
Biopharmaceutical ProductsInnovative APIs
Service Types
Biopharmaceutical ServicesContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Laboratory and Analytical Services
Product Categories
PeptidesChinese Hamster Ovaries (CHO) and cell linesContinuous BioprocessingMonoclonal Antibodies
Service Categories
Method DevelopmentMethod ValidationAnalytical Chemistry (Biopharmaceutical Services)Drug DiscoveryFormulation development
Company Certification
OtherISOGMP
